| Announce Date | 01/16/2026 |
| EPS Normalized Actual | $4.88 (Beat by $0.68) |
| EPS GAAP Actual | $4.88 (Beat by $0.68) |
| Revenue Actual | $6.071B |
| Revenue Surprise | Beat by $6071M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.98941 |
| EPS GAAP Estimate | $3.98941 |
| Revenue Estimate | $8.764191141B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 16.39 | 13.99 | 16.05089 | 16.65331 | 2 |
| Dec 2027 | 14.07 | 16.3 | 13.70033 | 14.32393 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 4.88 | 1.11671 | 6.071B | 9.11% | 345.65M |
| FQ3 2025 (Sep 2025) | 4.36 | 0.98366 | 8.794B | 37.89% | 3208.3M |
| FQ2 2025 (Jun 2025) | -3.52 | -6.83838 | 3.012B | -166.9% | -2559.77M |
| FQ1 2025 (Mar 2025) | 3.52 | 3.52 | 5.233B | -60.16% | 5233M |
| FQ4 2024 (Dec 2024) | 3.87 | 3.87 | 5.518B | 3.48% | 5518M |
| FQ3 2024 (Sep 2024) | 3.033 | 3.033 | 5.462B | 4.17% | 5462M |
| FQ2 2024 (Jun 2024) | 3.65 | 3.65 | 8.039B | 33.74% | 8039M |
| FQ1 2024 (Mar 2024) | 3.33 | 3.33 | 8.381B | 33.48% | 8381M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
3.98941
Consensus Revenue Estimates
8.764191141B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 5.2695 | -- | 5.2695 | 5.2695 | 15 |
| FQ3 2027 (Sep 2027) | 5.12185 | -- | 5.12185 | 5.12185 | 8 |
| FQ2 2027 (Jun 2027) | 4.77905 | -- | 4.77905 | 4.77905 | 8 |
| FQ1 2027 (Mar 2027) | 4.5131 | -- | 4.5131 | 4.5131 | 8 |
| FQ4 2026 (Oct 2026) | 4.0065 | -21.8 | 4.0065 | 4.0065 | 5 |
| FQ3 2026 (Jul 2026) | 3.7473 | -16.35 | 3.7473 | 3.7473 | 5 |
| FQ2 2026 (Jun 2026) | 4.20902 | 183.63 | 4.15839 | 4.25106 | 10 |
| FQ1 2026 (Mar 2026) | 3.98941 | 11.77 | 3.94142 | 4.02925 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.58B | -- | 6.58B | 6.58B | 7 |
| FQ3 2027 (Sep 2027) | 6.49B | -- | 6.49B | 6.49B | 8 |
| FQ2 2027 (Jun 2027) | 6.34B | -- | 6.34B | 6.34B | 7 |
| FQ1 2027 (Mar 2027) | 6.2B | -- | 6.2B | 6.2B | 10 |
| FQ4 2026 (Oct 2026) | 9.62B | 36.9 | 9.62B | 9.62B | 10 |
| FQ3 2026 (Jul 2026) | 9.5B | 7.46 | 9.5B | 9.5B | 10 |
| FQ2 2026 (Jun 2026) | 8.87B | 66.05 | 8.79B | 8.94B | 9 |
| FQ1 2026 (Mar 2026) | 8.76B | 40.29 | 8.68B | 8.83B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.76329 | 4.88 | 1.11671 | 22.88% |
| FQ3 2025 (Sep 2025) | 3.37634 | 4.36 | 0.98366 | 22.56% |
| FQ2 2025 (Jun 2025) | 3.31838 | -3.52 | -6.83838 | 194.27% |
| FQ1 2025 (Mar 2025) | 3.52 | 3.52 | 100% | |
| FQ4 2024 (Dec 2024) | 3.87 | 3.87 | 100% | |
| FQ3 2024 (Sep 2024) | 3.033 | 3.033 | 100% | |
| FQ2 2024 (Jun 2024) | 3.65 | 3.65 | 100% | |
| FQ1 2024 (Mar 2024) | 3.33 | 3.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $5.73B | $6.07B | $345.65M | 5.69% |
| FQ3 2025 (Sep 2025) | $5.59B | $8.79B | $3208.3M | 36.48% |
| FQ2 2025 (Jun 2025) | $5.57B | $3.01B | $-2559.77M | -84.99% |
| FQ1 2025 (Mar 2025) | $0B | $5.23B | $5233M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.52B | $5518M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $5.46B | $5462M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $8.04B | $8039M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $8.38B | $8381M | 100% |